Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001193125-26-076892·COLUMN GROUP III, LP
Schedule 13D ownership disclosure
Tenaya Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 87990A106
Event date: 2026-02-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- The Column Group III, LPReported CIK 0001668159
Shares: 0 · Class: 0%
- The Column Group III-A, LPReported CIK 0001668085
Shares: 0 · Class: 0%
- The Column Group III GP, LPReported CIK 0001790965
Shares: 0 · Class: 0%
- The Column Group Opportunity III, LPReported CIK 0001931825
Shares: 49,313,559 · Class: 23.1%
- The Column Group Opportunity III GP, LPReported CIK 0001932874
Shares: 49,313,559 · Class: 23.1%
- TCG Opportunity III GP, LLCReported CIK 0001932445
Shares: 49,313,559 · Class: 23.1%
- Tim KutzkeyReported CIK 0001614186
Shares: 49,313,559 · Class: 23.1%
- Peter SvennilsonReported CIK 0001606074
Shares: 49,313,559 · Class: 23.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-076892
- Form type
- SCHEDULE 13D/A
- Filer
- COLUMN GROUP III, LP
- CIK
- CIK 1668159
- Filed
- Feb 26, 2026
- Reporting period
- Feb 25, 2026
- Description
- Schedule 13D beneficial ownership